Northfield

This is the limited version of the Northfield company profile: Join LinkedIn or Sign In to see more information.

We are a leader in developing a hemoglobin-based oxygen-carrying red blood cell substitute. The initial indication we are seeking for our product PolyHeme® is the treatment of life-threatening hemoglobin levels when blood transfusion is indicated but red blood cells may not be available, appropriate or acceptable. PolyHeme® is a solution of chemically modified human hemoglobin that requires no cross-matching and is therefore compatible with all blood types. It has an extended shelf life in excess of 12 months.

Your Connections to Northfield

To see how you’re connected: Join Now or Sign In

Popular Profiles at Northfield

Last edited by Senior Corporate Communications Professional

In partnership with BusinessWeek

Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.

This LinkedIn Company Profile was created by LinkedIn and is about Northfield. This page is not endorsed by or affiliated with Northfield. For questions regarding LinkedIn Company Profiles, contact us.

Northfield (NFLD) full company profile, stock quotes, financial statements and more.

Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions